Stone, Meredith L.
Lee, Jesse
Lee, Jae W.
Coho, Heather
Tariveranmoshabad, Mito
Wattenberg, Max M. http://orcid.org/0000-0002-8120-1132
Choi, Hana
Herrera, Veronica M.
Xue, Yuqing http://orcid.org/0000-0002-8909-0270
Choi-Bose, Shaanti
Zingone, Sofia K.
Patel, Dhruv
Markowitz, Kelly
Delman, Devora
Balachandran, Vinod P.
Beatty, Gregory L. http://orcid.org/0000-0001-7165-5993
Article History
Received: 6 June 2023
Accepted: 15 March 2024
First Online: 19 April 2024
Competing interests
: J.L. has received compensation for prior consulting work from Anchor Molecular and Prescient Medicine unrelated to this work. G.L.B. reports prior or active roles as a consultant/advisory board member for Adicet Bio, Aduro Biotech, Alligator Biosciences, AstraZeneca, BiolineRx, BioMarin Pharmaceuticals, Boehinger Ingelheim, Bristol-Myers Squibb, Cantargia, Cour Pharmaceuticals, Genmab, HotSpot Therapeutics, Incyte, Janssen, Legend Biotech, Merck, Molecular Partners, Monopteros, Nano Ghosts, Opsona, Pancreatic Cancer Action Network, Seagen, Shattuck Laboratories and Verastem; reports receiving commercial research grants from Alligator Biosciences, Gilead Sciences, Incyte, Bristol-Myers Squibb, Verastem, Halozyme, Biothera, Hibercell, Newlink, Novartis, Arcus and Janssen. G.L.B. is an inventor of intellectual property (US patent numbers 10,640,569 and 10,577,417) and recipient of royalties related to CAR T cells that is licensed by the University of Pennsylvania to Novartis and Tmunity Therapeutics. M.M.W. reports prior or active roles as a consultant for Nanology. The other authors declare no competing interests.